Clinical trial
Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)
NCT00217178 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)
- Lead sponsor
- Hamilton Health Sciences Corporation
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2000
- Completion date
- October 31, 2005
- Enrollment
- 900
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, cardiovascular disease